Popular Stories

Obesity Tag

  • All
  • Biotechnology
  • Cannabis
  • Investing Ideas
  • Macro
  • Miscellaneous
  • Sectors
  • Startups
  • Technologies
  • Trending
  • Uncategorized
Aravive Reports Positive Data from Phase 1b Ovarian Cancer Trial

Aravive, Inc. (NASDAQ: ARAV), a clinical stage biotechnology Company engaged in developing therapeutics for solid tumours and hematologic malignancies, announced positive data from its ongoing Phase 1b/2 study of AVB-500, intended for treatment of Ovarian cancer patients. The results were presented at the European Society...

Is Autologous Stem Cell Therapy the next frontier of medicine?

Stem Cell Therapy is emerging as the future of therapeutics for numerous diseases and disorders which have hitherto been unaddressed. The growing awareness of the regenerative powers of stem cells, along with rising research and development expenditure on stem cell technology will drive the growth...

WordPress Video Lightbox Plugin